Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
With
Children's Cancer Research Fund
Age
8–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Initial Screening and Registration
Previous diagnosis of acute lymphoblastic leukemia or brain tumor and have been off treatment and in disease-free remission for a minimum of one year; treated at the University of Minnesota Medical Center, Fairview.
Proficient in English
Have given informed consent (assent)
After Initial Screening
Have evidence of attention impairment based on parent report of attention deficit (\> and = 75% on attention deficit hyperactivity disorder \[ADHD\] Index, Hyperactivity, or Cognitive-Problems/Inattention Index of parent-completed attention deficit hyperactivity disorder (ADHD) rating scale \[Conners Parent Rating Scale\] and perform at least 1.0 standard deviations below the mean on Omissions, Commissions, or Variability indexes of the Test of Variables of Attention (TOVA)
Have an estimated Full Scale IQ score on the Wechsler Abbreviated Scale of Intelligence (WASI) \>55.
You may not be if
Have optic pathway gliomas and/or neurofibromatosis
Diagnosed with ADD/ADHD prior to their cancer diagnosis
Currently taking antidepressants or antipsychotics
Currently being treated with stimulant medication
Blind
Have glaucoma
Have a family or personal history of motor or phonic tics or Tourette syndrome
Have seizures not controlled by antiepileptic drugs
Taking an MAO-inhibitor
Have a history of cardiovascular disease, uncontrolled hypertension, or hyperthyroidism, or current hypertension requiring antihypertensives
Clareo Health | Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
